4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methyl-1- piperazinyl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)-,
AZD 0530,
AZD-0530,
AZD0530,
AZD0530 Difumarate,
N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-((tetrahydro- 2H-pyran-4-yl)oxy)quinazolin-4-amine bi((2E)-but-2-enedioate),
N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine,
saracatinib,
saracatinib difumerate,
SARACATINIB DIFUMARATE,
UNII-8R1DYT4EAW,
893428-72-3,
8R1DYT4EAW,
Saracatinib difumarate [USAN],
Saracatinib difumarate (USAN),
AZD 0530 difumarate,
AZD-0530 difumarate,
AZD0530 DIFUMARATE,
C35H40ClN5O13,
SCHEMBL4260310,
SCHEMBL4260314,
CHEMBL2105677,
(5-CHLORO-BENZO[1,3]DIOXOL-4-YL)-[7-[2-(4-METHYL-PIPERAZIN-1-YL)-ETHOXY]-5-(TETRAHYDRO-PYRAN-4-YLOXY)-QUINAZOLIN-4-YL]-AMINE (2E)-2-BUTENEDIOATE (1:2),
Y1467,
D09665,
Z-3301,
4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methyl-1- piperazinyl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)-, (2E)-2-butenedioate (1:2),
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-((tetrahydro- 2H-pyran-4-yl)oxy)quinazolin-4-amine bis((2E)-but-2-enedioate),
Saracatinib,
379231-04-6,
4-QuinazolinaMine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-Methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2),